Enrichment of IL-12-producing plasmacytoid dendritic cells in donor bone marrow grafts enhances graft-versus-leukemia activity in allogeneic hematopoietic stem cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 9, 2013, Pages 1331-1339

  Darlak, Katarzyna A ^a   Wang, Ying ^a,b   Li, Jian Ming ^a   Harris, Wayne A C ^a   Owens, Lauren M ^a   Waller, Edmund K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Dendritic cell T cell; Graft versus leukemia; IL 12

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT VERSUS LEUKEMIA EFFECT; IN VIVO STUDY; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ALLOTRANSPLANTATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; PROCEDURES; TRANSPLANTATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; DENDRITIC CELLS; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84882783368     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.06.016     Document Type: Article

References (38)

1. Ferrara J.L., Cooke K.R., Teshima T. The pathophysiology of acute graft-versus-host disease. Int J Hematol 2003, 78:181-187.
2. Ferrara J.L., Levine J.E., Reddy P., Holler E. Graft-versus-host disease. Lancet 2009, 373:1550-1561.
3. Shlomchik W.D., Couzens M.S., Tang C.B., et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999, 285:412-415.
4. Waller E.K., Rosenthal H., Jones T.W., et al. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood 2001, 97:2948-2956.
5. Anasetti C., Logan B.R., Lee S.J., et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. NEngl J Med 2012, 367:1487-1496.
6. + T-cells and plasmacytoid dendritic cell precursors in allogeneic BM grafts from unrelated donors are associated with improved survival: results from BMT CTN 0201. ASH Annual Meeting Abstracts 2011, 118:1004.
7. + dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 2002, 100:383-390.
8. + DC1 precursors. Blood 2003, 101:1453-1459.
9. Pulendran B., Smith J.L., Caspary G., et al. Distinct dendritic cell subsets differentially regulate the class of immune response invivo. Proc Natl Acad Sci USA 1999, 96:1036-1041.
10. Gilliet M., Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. JExp Med 2002, 195:695-704.
11. Colonna M., Trinchieri G., Liu Y.J. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004, 5:1219-1226.
12. Ito T., Amakawa R., Kaisho T., et al. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. JExp Med 2002, 195:1507-1512.
13. Mittag D., Proietto A.I., Loudovaris T., et al. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. JImmunol 2011, 186:6207-6217.
14. MacDonald K.P., Kuns R.D., Rowe V., et al. Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during GVHD. Blood 2007, 109:5049-5057.
15. Markey K.A., Banovic T., Kuns R.D., et al. Conventional dendritic cells are the critical donor APC presenting alloantigen after experimental bone marrow transplantation. Blood 2009, 113:5644-5649.
16. Li J.M., Southerland L.T., Lu Y., et al. Activation, immune polarization, and graft-versus-leukemia activity of donor T cells are regulated by specific subsets of donor bone marrow antigen-presenting cells in allogeneic hemopoietic stem cell transplantation. JImmunol 2009, 183:7799-7809.
17. Lu Y., Giver C.R., Sharma A., et al. Interferon-gamma and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity. Blood 2012, 119:1075-1085.
18. Gillis S., Mizel S.B. T-cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation. Proc Natl Acad Sci USA 1981, 78:1133-1137.
19. Waller E.K., Ship A.M., Mittelstaedt S., et al. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease. Blood 1999, 94:3222-3233.
20. Cooke K.R., Kobzik L., Martin T.R., et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation, IL: the roles of minor H antigens and endotoxin. Blood 1996, 88:3230-3239.
21. Li J.M., Gorechlad J., Larsen C.P., Waller E.K. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 2006, 12:1239-1249.
22. Giver C.R., Montes R.O., Mittelstaedt S., et al. Exvivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects. Biol Blood Marrow Transplant 2003, 9:616-632.
23. + T cell activity. JImmunol 1993, 150:197-205.
24. Anderson B.E., McNiff J.M., Jain D., et al. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ. Blood 2005, 105:2227-2234.
25. Highfill S.L., Rodriguez P.C., Zhou Q., et al. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 2010, 116:5738-5747.
26. Li J.M., Waller E.K. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 2004, 10:540-551.
27. Yang Y.G., Sergio J.J., Pearson D.A., et al. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood 1997, 90:4651-4660.
28. +, Tc1/Tc2 populations in murine GVL: type I cells generate GVL and type II cells abrogate GVL. Biol Blood Marrow Transplant 1996, 2:118-125.
29. + Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. JImmunol 1996, 157:4811-4821.
30. + dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis. JImmunol 2008, 181:2483-2493.
31. Park M.J., Park K.S., Park H.S., et al. Adistinct tolerogenic subset of splenic IDO(+)CD11b(+) dendritic cells from orally tolerized mice is responsible for induction of systemic immune tolerance and suppression of collagen-induced arthritis. Cell Immunol 2012, 278:45-54.
32. Wang Y., Fan K.T., Li J.M., Waller E.K. The regulation and activity of interleukin-12. Front Biosci (Schol Ed) 2012, 4:888-899.
33. Carson W.E., Giri J.G., Lindemann M.J., et al. Interleukin (IL)-15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. JExp Med 1994, 180:1395-1403.
34. Micallef M.J., Ohtsuki T., Kohno K., et al. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol 1996, 26:1647-1651.
35. Stern A.S., Magram J., Presky D.H. Interleukin-12 an integral cytokine in the immune response. Life Sci 1996, 58:639-654.
36. Hanash A.M., Dudakov J.A., Hua G., et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft-versus-host disease. Immunity 2012, 37:339-350.
37. Robb R.J., Kreijveld E., Kuns R.D., et al. Type I-IFNs control GVHD and GVL responses after transplantation. Blood 2011, 118:3399-3409.
38. Asselin-Paturel C., Boonstra A., Dalod M., et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2001, 2:1144-1150.